Wayfinder Biosciences Partners with Daiichi Sankyo to Develop Therapies for Neurodegenerative Diseases

Wayfinder Biosciences has entered into a collaboration with Daiichi Sankyo to develop RNA-targeting small molecule therapies aimed at treating neurodegenerative diseases.

Wayfinder, a biotechnology company specialising in RNA-targeting technologies, has developed a platform that identifies potent and selective small molecules. These molecules are designed to bind directly to RNA, neutralising the harmful effects of disease-related genes. Unlike traditional drugs that often target proteins, this approach enables access to previously undruggable targets.

The company’s proprietary platform integrates RNA-based sensors and a data generation engine to provide scalable, quantitative insights into how small molecules bind to RNA. It also assesses their selectivity and biological activity. While the technology is currently being used internally for oncology research, it has broad potential across other disease areas.

This new partnership brings together Wayfinder’s RNA-focused platform with Daiichi Sankyo’s drug discovery and development expertise. The joint effort will support the launch of a programme to address a key target in neurodegeneration. 

The collaboration is expected to accelerate the development of innovative treatments in a field where new therapeutic approaches are urgently needed.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!